594 related articles for article (PubMed ID: 21741957)
1. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
[TBL] [Abstract][Full Text] [Related]
2. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
3. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
[TBL] [Abstract][Full Text] [Related]
4. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation.
Ho SY; Chen WC; Chiu HW; Lai CS; Guo HR; Wang YJ
Chem Biol Interact; 2009 May; 179(2-3):304-13. PubMed ID: 19159621
[TBL] [Abstract][Full Text] [Related]
5. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L
Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890
[TBL] [Abstract][Full Text] [Related]
6. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
Hsu WH; Hsieh YS; Kuo HC; Teng CY; Huang HI; Wang CJ; Yang SF; Liou YS; Kuo WH
Arch Toxicol; 2007 Oct; 81(10):719-28. PubMed ID: 17673978
[TBL] [Abstract][Full Text] [Related]
7. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
[TBL] [Abstract][Full Text] [Related]
8. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
[TBL] [Abstract][Full Text] [Related]
9. Role of p38 MAPK and JNK in enhanced cervical cancer cell killing by the combination of arsenic trioxide and ionizing radiation.
Kang YH; Lee SJ
Oncol Rep; 2008 Sep; 20(3):637-43. PubMed ID: 18695917
[TBL] [Abstract][Full Text] [Related]
10. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
11. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
12. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
13. BBR induces apoptosis in HepG2 cell through an Akt-ASK1-ROS-p38MAPKs-linked cascade.
Hyun MS; Hur JM; Mun YJ; Kim D; Woo WH
J Cell Biochem; 2010 Feb; 109(2):329-38. PubMed ID: 19950206
[TBL] [Abstract][Full Text] [Related]
14. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells.
Kim BM; Choi YJ; Han Y; Yun YS; Hong SH
Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559
[TBL] [Abstract][Full Text] [Related]
15. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ
Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268
[TBL] [Abstract][Full Text] [Related]
17. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
18. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.
Lee KB; Kim KR; Huh TL; Lee YM
Int J Oncol; 2008 Dec; 33(6):1247-56. PubMed ID: 19020758
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
Li X; Ding X; Adrian TE
Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
[TBL] [Abstract][Full Text] [Related]
20. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]